Letters

Vaccination against hepatitis A for travellers

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6971.61b (Published 07 January 1995) Cite this as: BMJ 1995;310:61

Will alter the dynamics of transmission in Britain

  1. Keith Neal
  1. Lecturer in communicable disease control Department of Public Health Medicine and Epidemiology, Faculty of Medicine, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH

    EDITOR,—R H Behrens and J A Roberts suggest that vaccination against hepatitis A is not cost effective and recommend that travellers should contribute more to the true cost.1 This requires debate, but their work also raises several public health issues. Hepatitis A is endemic in Britain,2 3 and on average each case of infection results in one secondary case4; this is a feature common to infectious diseases, which allows them to persist. Hepatitis A associated with travel may cause …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe